Citigroup Maintains Buy on GE HealthCare Techs, Raises Price Target to $103
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has maintained a Buy rating on GE HealthCare Techs (NASDAQ:GEHC) and increased the price target from $88 to $103, indicating a positive outlook on the company's stock.
April 03, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup has reaffirmed its Buy rating on GE HealthCare Techs and raised the price target from $88 to $103, signaling confidence in the company's future performance.
The increase in price target by a reputable analyst such as Joanne Wuensch from Citigroup typically signals a strong bullish sentiment on the stock. This is based on the expectation of improved performance or favorable market conditions for GE HealthCare Techs, which could lead to an increase in investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100